Filtered By:
Condition: Patent Foramen Ovale
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 1415 results found since Jan 2013.
Net clinical benefit of PFO closure versus medical treatment in patients with cryptogenic stroke: A systematic review and meta-analysis
CONCLUSION: The NCB between PFO closure and medical treatment was not different, suggesting individualized treatment to maximize benefit.PMID:36584788 | DOI:10.1016/j.hjc.2022.12.010
Source: Hellenic Journal of Cardiology - December 30, 2022 Category: Cardiology Authors: Konstantinos Kolokathis Costas Thomopoulos Konstantinos Tsioufis Source Type: research
Atrial cardiopathy in young adults with embolic stroke of undetermined source: a myocardial deformation imaging analysis
ConclusionThis study shows that in our population atria cardiopathy and atrial function was not associated with ESUS.LAA structural and functional abnormalities may play a major role. The role of LAA in ESUS warrants further studies.
Source: The International Journal of Cardiovascular Imaging - December 21, 2022 Category: Radiology Source Type: research
Transcatheter Patent Foramen Ovale Closure in Patients With Transient Ischemic Attack
The objectives of this study were to determine the clinical and procedural characteristics and long-term outcomes of patients with TIA who underwent transcatheter PFO closure. This was a multicenter study including 1,012 consecutive patients who underwent PFO closure after a cerebrovascular event. Patients were divided into 2 groups according to their index event leading to PFO closure: TIA (n = 183 [18%]), and stroke (n = 829 [82%]).
Source: The American Journal of Cardiology - December 14, 2022 Category: Cardiology Authors: Julio I. Farjat-Pasos, Paul Guedeney, Christine Houde, Alberto Alperi, Mathieu Robichaud, M élanie Côté, Gilles Montalescot, Josep Rodés-Cabau Source Type: research
Potential Embolic Sources in Embolic Stroke of Undetermined Source Patients with Patent Foramen Ovale
Conclusion: A large proportion of ESUS patients with PFOs had concomitant PESs. The presence of concomitant PESs was associated with older age and a lower RoPE score. Further, large cohort studies are warranted to investigate the significance of the PES and their overlap with PFOs in ESUS.Cerebrovasc Dis
Source: Cerebrovascular Diseases - December 1, 2022 Category: Neurology Source Type: research
EE99 Cost-Effectiveness of Percutaneous Closure of a Patent Foramen Ovale (PFO) Versus Antiplatelet Therapy After Stroke: A Trial and Model Based Economic Evaluation of the French Close Randomised Controlled Trial
The French RCT CLOSE demonstrated that patients having experienced cryptogenic stroke and having a patent foramen ovale (PFO) with echocardiographic features representing risk of stroke benefited from PFO closure compared to antiplatelet therapy. This analysis determines the cost-effectiveness from the perspective of the French healthcare system of percutaneous PFO closure in combination with antiplatelet therapy versus antiplatelet therapy alone using economic data collected during the CLOSE trial.
Source: Value in Health - December 1, 2022 Category: International Medicine & Public Health Authors: M Darlington, Y Gaston, A Charles-Nelson, G Chatellier, JL Mas, I Durand-Zaleski Source Type: research
The Serious Side of Supplements: An Ischemic Stroke in a Healthy 38-year-old Female
We present a case of a healthy, 38-year-old female military dependent who presented with an ischemic right posterior central gyrus stroke in the setting of a patent foramen ovale and supplement diindolylmethane use. This case serves as a reminder of the hazards associated with supplement use and the importance of a thorough investigation of etiology in medical cases of ischemic stroke in the young.PMID:36448494 | DOI:10.1093/milmed/usac367
Source: Military Medicine - November 30, 2022 Category: International Medicine & Public Health Authors: Sierra T Pence Ketan Mehta Jennifer Crum-Bailey Source Type: research
Percutaneous Patent Foramen Ovale Closure After Stroke
Korean Circ J. 2022 Nov;52(11):801-807. doi: 10.4070/kcj.2022.0258.ABSTRACTPercutaneous patent foramen ovale (PFO) closure in patients with a prior PFO-associated stroke showed a risk reduction of the stroke recurrence compared to the medical therapy alone in recent several studies. Nevertheless, optimal patient selection for PFO closure has not been clarified. In this paper, we discuss the characteristics of PFO-associated strokes and discuss the recently published evidence and patient selection for PFO closure in patients with ischemic stroke. The lesions characteristics of PFO-associated stroke are associated with multi...
Source: Korean Circulation Journal - November 8, 2022 Category: Cardiology Authors: Oh-Hyun Lee Jung-Sun Kim Source Type: research
